Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
Stopped Slow accrual within enrollment time period: projected accrual goal not achieved.
Conditions
- Simultaneous Kidney and Pancreas Transplantation
Interventions
- BIOLOGICAL: Belatacept
- DRUG: methylprednisolone
- BIOLOGICAL: Anti-thymocyte Globulin (Rabbit)
- DRUG: Tacrolimus
- DRUG: Mycophenolate mofetil
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
- [object Object]
- [object Object]
- [object Object]